Antares Pharma, Inc. (ATRS)

SG&A Expense Growth

17.68%

Fiscal year · Period ending:

ATRS logo

ATRS SG&A Expense Growth

Latest reported17.68%
ATRS FY SG&A Growth (YoY) (0.00% → 17.68%)
High-resolution chart · PNG

ATRS sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
17.6835%
1.5962%
68.0349%
21.1149%
14.9961%
-1.9904%
-15.1524%
86.6172%
77.4452%
29.5494%
28.2405%
-3.236%
-25.214%
3.5635%
6.7605%
15.047%
1.0611%
-10.3649%
14.7427%
-10.0293%
157.6415%
-9.9742%
-15.7017%
1.9552%
39.135%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.